Atlas Trials

Desensitization With Belimumab in Sensitized Patients Awaiting Kidney Transplant

Clinical trial NCT01025193 · TERMINATED

Trial details

NCT number
NCT01025193
Sponsor
University of Pennsylvania
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Desensitization
Start date
2010-02-01
Primary completion
2011-10-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.